What’s new

• Deep Health AI India sold 15.1 million shares (3.38% stake) in Exxaro Tiles over four months.
• The sale reduced its holding from 8.23% to 5.98%, reversing a prior accumulation trend.
• Despite also buying 1.13% during the same period, net outflow was significant.

Why it matters

For a ₹310 cr nano-cap, a 3.38% stake sale by the largest non-promoter investor is material. It changes the ownership structure, could pressure liquidity and sentiment, especially since the investor had been buying earlier. Exxaro's already weak profitability (PAT down 94%) adds to the concern.

What we’re watching

• Will Deep Health AI continue to sell below the 5% threshold?
• Whether institutional or retail buyers step in.
• Impact on Exxaro's already weak profitability (PAT down 94% trailing).

The full read

Deep Health AI India Limited sold 15.1 million shares (3.38%) in Exxaro Tiles between February and June 2026. A sharp reversal. The investor, which had been accumulating the stock since late 2025, also bought 1.13% during the same period, but the net reduction dominated—dropping its stake from 8.23% to 5.98%. For a ₹310 cr nano-cap with trailing PAT down 94%, this ownership shift changes the investor base meaningfully. It signals a potential loss of strategic interest. The sale was spread over four months, orderly rather than panicked. The open question is whether Deep Health AI will continue selling below the 5% threshold, which would end its disclosure obligations entirely.

Primary source: BSE · NSE